Emerging Markets Earnings Roundup: Amgen, Sanofi (Part 14)
This article was originally published in PharmAsia News
Executive Summary
Amgen is fairly quiet on international in the second quarter, but Sanofi says it is back on track in Brazil and emerging markets generally.